Insights

Leadership Expansion Pliant Therapeutics has recently strengthened its leadership team by appointing industry veterans Steve Krognes, S. Mishima Gerhart, and Minnie Kuo to key roles, indicating a focus on expertise and experience in driving the company's growth and innovation.

Clinical Trials Progress With the launch of the BEACON-IPF study and the announcement of positive interim data from the Phase 2a trial of bexotegrast, Pliant Therapeutics is advancing in the development of treatments for fibrotic diseases, presenting potential collaboration opportunities with healthcare providers and research institutions.

Strategic Location Being located in South San Francisco, a renowned hub for biotechnology, Pliant Therapeutics is strategically positioned to leverage the local ecosystem of research institutions, biotech companies, and investors, paving the way for partnerships and business collaborations within the industry.

Financial Strength With a healthy revenue range of $10M - $50M and substantial funding of $288M, Pliant Therapeutics demonstrates financial stability and growth potential, making it an attractive partner for investors, pharmaceutical companies, and potential acquirers.

Focus on IPF Treatment As a specialized biopharmaceutical company focusing on developing treatments for idiopathic pulmonary fibrosis (IPF), Pliant Therapeutics offers a niche expertise that can lead to strategic collaborations with organizations or investors specifically interested in advancements in IPF therapies.

Pliant Therapeutics Tech Stack

Pliant Therapeutics uses 8 technology products and services including Drupal, Vue.js, Module Federation, and more. Explore Pliant Therapeutics's tech stack below.

  • Drupal
    Content Management System
  • Vue.js
    Javascript Frameworks
  • Module Federation
    Miscellaneous
  • Webpack
    Miscellaneous
  • Amazon Web Services
    Platform As A Service
  • Adobe Tag Manager
    Tag Management
  • YouTube
    Video Players
  • EmbedPlus
    Web Platform Extensions

Media & News

Pliant Therapeutics's Email Address Formats

Pliant Therapeutics uses at least 1 format(s):
Pliant Therapeutics Email FormatsExamplePercentage
FLast@pliantrx.comJDoe@pliantrx.com
94%
Last@pliantrx.comDoe@pliantrx.com
3%
FirstLast@pliantrx.comJohnDoe@pliantrx.com
2%
LastFirst@pliantrx.comDoeJohn@pliantrx.com
1%

Frequently Asked Questions

Where is Pliant Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Pliant Therapeutics's main headquarters is located at 260 Littlefield Ave South San Francisco, California 94080 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Pliant Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Pliant Therapeutics's main corporate office by phone at +1-650-481-6786. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Pliant Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Pliant Therapeutics is a publicly traded company; the company's stock symbol is PLRX.

What is Pliant Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Pliant Therapeutics's official website is pliantrx.com and has social profiles on LinkedIn.

How much revenue does Pliant Therapeutics generate?

Minus sign iconPlus sign icon
As of August 2024, Pliant Therapeutics's annual revenue reached $35M.

What is Pliant Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Pliant Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Pliant Therapeutics have currently?

Minus sign iconPlus sign icon
As of August 2024, Pliant Therapeutics has approximately 187 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: P. A.Chief Development Officer: M. K.Chief Financial Officer: K. C.. Explore Pliant Therapeutics's employee directory with LeadIQ.

What industry does Pliant Therapeutics belong to?

Minus sign iconPlus sign icon
Pliant Therapeutics operates in the Biotechnology Research industry.

What technology does Pliant Therapeutics use?

Minus sign iconPlus sign icon
Pliant Therapeutics's tech stack includes DrupalVue.jsModule FederationWebpackAmazon Web ServicesAdobe Tag ManagerYouTubeEmbedPlus.

What is Pliant Therapeutics's email format?

Minus sign iconPlus sign icon
Pliant Therapeutics's email format typically follows the pattern of . Find more Pliant Therapeutics email formats with LeadIQ.

How much funding has Pliant Therapeutics raised to date?

Minus sign iconPlus sign icon
As of August 2024, Pliant Therapeutics has raised $288M in funding. The last funding round occurred on Jan 24, 2023 for $288M.

When was Pliant Therapeutics founded?

Minus sign iconPlus sign icon
Pliant Therapeutics was founded in 2015.
Pliant Therapeutics

Pliant Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Pliant Therapeutics is a late-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. At Pliant, we share a commitment and a clear passion to drive innovative science towards addressing areas of unmet medical need. Together we believe we have the power to make a difference in the lives of patients and those impacted by fibrotic diseases. 

We believe that by harnessing the therapeutic potential of integrin biology and TGF-β modulation, there is a potential to create drug candidates aimed at halting or even reversing fibrotic diseases.

Pliant recognizes the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. Pliant is an equal opportunity employer and does not discriminate against any individual or potential candidate based on race, color, religion, sex, national origin, sexual preference or any other legally protected category.

Pliant is located in South San Francisco, California, the birthplace of biotechnology. Proud to be a San Francisco Business Times Best Place to Work in 2023.

Learn more about how we are breaking ground in the treatment of fibrotic diseases at www.PliantRx.com.

Section iconCompany Overview

Headquarters
260 Littlefield Ave South San Francisco, California 94080 US
Phone number
+1-650-481-6786
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PLRX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $288M

    Pliant Therapeutics has raised a total of $288M of funding over 5 rounds. Their latest funding round was raised on Jan 24, 2023 in the amount of $288M.

  • $10M$50M

    Pliant Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $288M

    Pliant Therapeutics has raised a total of $288M of funding over 5 rounds. Their latest funding round was raised on Jan 24, 2023 in the amount of $288M.

  • $10M$50M

    Pliant Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.